PCSK9 Inhibitors in Combination With Advanced Treatment Strategies for the Treatment of Advanced Colorectal Cancer With pMMR/MSS

Conditions: Colorectal Cancer Interventions: Drug: PCSK9 inhibitor in combination with standard advanced first-line regimen group; Drug: standard advanced first-line regimen group Sponsors: Guangdong Provincial People ' s Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials